# STRIBILD
> **NDA203100** · New Drug Application · Sponsor: GILEAD SCIENCES INC · Approved 2012-08-27
## Drug
- **FDA Application Number:** NDA203100
- **Application type:** New Drug Application
- **Brand name:** STRIBILD
- **Generic name:** ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE
- **Active ingredients:** COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** GILEAD SCIENCES INC
- **Manufacturer:** Gilead Sciences, Inc.
- **First approval:** 2012-08-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203100)
---
*MORVS · CC0 1.0*